Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2005
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569910A2 Pesticidal sulphonylaminopyrazoles
09/07/2005EP1569907A1 Nicotinamide-based kinase inhibitors
09/07/2005EP1569900A2 Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
09/07/2005EP1569899A2 SUBSTITUTED 3-ALKYL AND 3-ARYLALKYL i 1H /i -INDOL-1-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1399434B1 Novel indole derivatives
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665808A Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665783A Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders
09/07/2005CN1665506A 2, 5-substituted pyrimidine derivatives as CCR-3 receptor antagonists IX
09/07/2005CN1665502A MCHIR antagonists
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/06/2005US6939977 For improved binding of CB1/CB2 receptors; side effects reduction
09/06/2005US6939970 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6 methoxyquinolin-4-propyl]-1-[2-2-thienylthio)ethyl] piperidine-3-carboxylic acid
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939882 Fungicides
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939007 wide range of color; ophthalmic lenses
09/06/2005CA2250395C Eprosartan dihydrate and a process for its production and formulation
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080380A1 Kinase inhibitors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
09/01/2005WO2005080372A1 Dihydropyridinone derivatives
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080354A1 1,2,4-triazines derivatives, preparation thereof and use thereof in human therapeutics
09/01/2005WO2005080346A1 Substituted azole derivatives, compositions, and methods of use
09/01/2005WO2005080343A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
09/01/2005WO2005080342A1 Pyridine derivatives and their use as cb2 receptor modulators
09/01/2005WO2005079802A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005WO2005079801A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079800A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005WO2005079791A1 Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
09/01/2005WO2005079319A2 C10 cyclopentyl ester substituted taxanes
09/01/2005WO2005066163A3 Thiophene derivatives as chk 1 inihibitors
09/01/2005WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005US20050192339 Compounds
09/01/2005US20050192331 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/01/2005US20050192320 (2-Carboxamido)(3-amino)thiophene compounds
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192294 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/01/2005US20050192293 Vanilloid receptor VR1 modulators; pain, inflammation, traumatic injury, autoimmune disease; compounds are pyridine subsituted at 2 position with an amido-, sulfoamido- or thioamide-substituted (N-hetero)aryl ring
09/01/2005US20050192292 Pyrrolidone carboxamides
09/01/2005US20050192287 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
09/01/2005US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
09/01/2005US20050191571 Polymeric charge transport compositions for organophotoreceptors
09/01/2005CA2556480A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555402A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1569039A2 Polymeric charge transport compositions for organophotoreceptors
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567597A1 Process for the production of meso-substituted cyanine dyes
08/31/2005EP1567519A2 Crystalline derivatives of 2-(5-chlorothien-2-yl)-n-((3s)-1((1s)-1-methyl-2-morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethensulfonamide
08/31/2005EP1567518A2 Oxime ester photoinitiators with heteroaromatic groups
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1567496A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
08/31/2005EP1567489A1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567151A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
08/31/2005EP1567010A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1366038B1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics
08/31/2005EP1289963B1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2005CN1662628A Solution-processable phosphorescent materials
08/31/2005CN1662527A Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 523